- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 211/03 - Monoamines
Détention brevets de la classe C07C 211/03
Brevets de cette classe: 135
Historique des publications depuis 10 ans
|
8
|
5
|
12
|
8
|
6
|
8
|
13
|
2
|
7
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Rhodia Operations | 1553 |
6 |
| BASF SE | 21087 |
4 |
| Beijing Research Institute of Chemical Industry, China Petroleum & Chemical Corporation | 294 |
4 |
| Cellix Bio Private Limited | 52 |
4 |
| China Petroleum & Chemical Corporation | 1950 |
4 |
| Arkema France | 4173 |
3 |
| Osaka University | 3382 |
3 |
| Regents of the University of Minnesota | 2738 |
3 |
| Cybin IRL Limited | 65 |
3 |
| Bristol-myers Squibb Company | 4820 |
2 |
| Centre National de La Recherche Scientifique | 10693 |
2 |
| The Board of Trustees of the University of Illinois | 2723 |
2 |
| CoorsTek Fluorochemicals, Inc. | 8 |
2 |
| Dorf Ketal Chemicals (India) Private Limited | 74 |
2 |
| Givaudan SA | 1909 |
2 |
| N.E. Chemcat Corporation | 189 |
2 |
| Neurocrine Biosciences, Inc. | 427 |
2 |
| Sanofi | 4131 |
2 |
| le Centre National de La Recherche Scientifique | 71 |
2 |
| London Pharmaceuticals and Research Corporation | 26 |
2 |
| Autres propriétaires | 79 |